热门资讯> 正文

Zimmer Biomet完成对Monogram Technology的收购

2025-10-07 22:23

Zimmer Biomet (NYSE:ZBH) has completed its $177M acquisition of Monogram Technologies (NASDAQ:MGRM), which was announced in July.
The acquisition provides Zimmer Biomet with Monogram's AI-driven, surgeon-guided, next-generation orthopedic robotics.
Terms of the deal have Monogram shareholders receiving $4.04 per share in cash, as well as up to $12.37 per share of common stock in cash if certain product development, regulatory, and revenue milestones are achieved through 2030.

More on Zimmer Biomet

Zimmer Biomet Holdings, Inc. (ZBH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Zimmer Biomet Holdings, Inc. (ZBH) Q2 2025 Earnings Call Transcript
Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA
Zimmer Biomet Non-GAAP EPS of $2.07 beats by $0.09, revenue of $2.08B beats by $20M
Zimmer Biomet Q2 2025 Earnings Preview

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。